Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1995-05-09
2000-04-25
Hutzell, Paula K.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
435 697, 435328, 435344, 5303873, 5303877, 5303888, 5303897, 4241301, 4241331, 4241551, 4241741, 4241381, A61K 39395, C12N 1513, C07K 1600, C07K 1630
Patent
active
060542977
ABSTRACT:
Variant immunoglobulins, particularly humanized antibody polypeptides are provided, along with methods for their preparation and use. Consensus immunoglobulin sequences and structural models are also provided.
REFERENCES:
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4845198 (1989-07-01), Urdal et al.
patent: 5132405 (1992-07-01), Huston et al.
patent: 5225539 (1993-07-01), Winter
patent: 5530101 (1996-06-01), Queen et al.
patent: 5558864 (1996-09-01), Bendig et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5677171 (1997-10-01), Hudziak et al.
patent: 5693761 (1997-12-01), Queen et al.
patent: 5693762 (1997-12-01), Queen et al.
patent: 5714350 (1998-02-01), Co et al.
patent: 5772997 (1998-06-01), Hudziak et al.
patent: 5821337 (1998-10-01), Carter et al.
patent: 5859205 (1999-01-01), Adair et al.
Garrido, M.A. Devel. Biol. Stand (Switzerland) 71: 33-42, 1990.
Queen et al., PNAS, USA, 86:10029-10033, 1989.
Foote, J. et al., Nova Acta Leopoldina NF 61 No. 269:103-110, 1989
Riechman, L. et al., Nature. 332(24):323-327, 1988.
Kabat, E.A. et al., Sequences of proteins of Immunological Interest, NIH, Bethesda, MD, pp. iii-xxvii, 41-175, 1987.
Margni, R.A. et al., Ann Rev. Immunol. 6:535-54, 1988.
Fendly, B.M. et al., Cancer Res. 50: 1550-1558, 1990.
Kuijpers K.C. et al., J. Immunol. 144(9): 3281-7, 1990
Brown, Jr. et al., "Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival" Proc. Natl. Acad. Sci. USA 88:2663-2667 (1991).
Casale et al., "Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis" J. Allergy Clin. Immunol. 100:110-121 (1997).
Fahy et al., "The Effect of an Anti-IgE Monoclonal Antibody on the Early-and Late-Phase Responses to Allergen Inhalation in Asthmatic Subjects" Am J. Respir. Crit. Care Med 155:1828-1834 (1997).
Mathieson et al., "Monoclonal-Antibody Therapy in Systemic Vasculitis" New England J. of Medicine pp. 250-254 Jul. 1990).
Osborne, Randall, "Full Approval of Breast Cancer Drug Expected by Year's End, FDA Panel OKs Genentech's Herceptin" Daily Ink pp. 1-2 (Sep. 4, 1998).
Presta et al., "Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders" Cancer Research 57 (20):4593-4599 (Oct. 15, 1997).
"Biosym Technologies" in new Products, Chemical Design Automation 3 (Dec. 1988).
"Polygen Corporation" in new Products, Chemical Design Automation 3 Nov. 1988).
Adair et al., "Humanization of the murine anti-human CD3 monoclonal antibody OKT3" Hum. Antibod. Hybridomas 5:41-47 (1994).
Chothia et al., "Principles of protein-protein recognition" Nature 256:705-708 (1975).
Chothia et al., "Transmission of conformational change in insulin" Nature 302:500-505 (1983).
Corti et al., "Idiotope Determining Regions of a Mouse Monoclonal Antibody and Its Humanized Versions" J. Mol. Biol. 235:53-60 (1994).
Couto et al., "Anti-BA46 Monoclonal Antibody Mc3 Humanization Using a Novel Positional Consensus and in Vivo and in Vitro Characterization" Cancer Research Supplement 55:1717-1722 (1995).
Couto et al., "Humanization of KC4G3, an Anti-Human Carcinoma Antibody" Hybridoma 13:215-219 (1994).
Ellis et al., "Engineered Anti-CD38 Monoclonal Antibodies for Immunotherapy of Multiple Myeloma" The Journal of Immunology pp. 925-937 (1995).
Hieter et al., "Evolution of Human Immunoglobulin K J Region Genes" The Journal of Biological Chemistry 257:1516-1522 (1982).
Lesk, Arthur M., "How Different Amino Acid Sequences Determine Similar Protein Structures: The Structure and Evolutionary Dynamics of the Globins" J. Mol. Biol. 136:225-270 (1980).
Matsumura et al., "Hydrophobic stabilization in T4 lysozyme determined directly by multiple substitutions of Ile 3" Nature 334:406-410 (1988).
Morrison, S. L., "Transfectomas Provide Novel Chimeric Antibodies" Science 229:1202-1207 (Sep. 20, 1985).
Nakatani et al., "Humanization of mouse anti-human IL-2 receptor antibody B-B10" Protein Engineering 7:435-443 (1994).
Ohtomo et al., "Humanization of Mouse ONS-M21 Antibody with the Aid of Hybrid Variable Regions" Molecular Immunology 32:407-637 (1977).
Padlan et al., "Model-Building Studies of Antigen-Binding Sites: The Hapten-Binding Site of MOPC-315" C.S. Harbor Symp. Quant. Biol. 41:627-637 (1977).
Rodrigues et al., "Engineering a humanized bispecific F(ab').sub.2 fragment for improved binding to T cells" Int. J. Cancer (Suppl.) 7:45-50 (1992).
Sha et al., "A heavy Chain Grafted Antibody that Recognizes the Tumor-Associated TAG72 Antigen" Cancer Biotherapy 9:341-349 (1994).
Tempest et al., "Identification of framework residues required to restore antigen binding during reshaping of a monoclonal antibody against the glycoprotein gB of human cytomegalovirus" Int. J. Biol. Macromol. 17:37-42 (1995).
Tramontano, "Structural Determinants of the Conformations of Medium-Sized Loops in Proteins" Proteins 6:382-394 (1989).
Uchiyama et al., "A Monoclonal Antibody (ANTI-Tac) Reactive with Activated and Functionally Mature Human T Cells" Journal of Immunology 126:1393-1397 (1981).
Vincenti et al., "Interleukin-2-Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation" New Engl. J. Med. 338:161-165 (1998).
Vitetta et al., "Redesigning Nature's Poisons to Create Anti-Tumor Reagents" Science 238:1098-1104 (1987).
Waldmann et al., "Interleukin 2 Receptor (Tac Antigen) Expression in HTLV-1-associated Adult T-Cell Leukemia" Cancer Research 45:4559s-4562s (1985).
Waldmann, Thomas A., "The Structure, Function, and Expression of Interleukin-2 Receptors on Normal and Malignant Lymphocytes" Science 232:727-732 (1986).
Wu et al., "An Analysis of the Sequences of the Variable Regions of Bence Jones Proteins and Myeloma Light Chains and Their Implications for Antibody Complementarity" Journal of Experimental Medicine 132:211-250 (1970).
Amit et al., "Three-Dimensional Structure of an Antigen-Antibody Complex at 2.8 A Resolution" Science 233:747-753 (Aug. 1986).
Amzel et al., "The Three Dimensional Structure of a Combining Region-Ligand Complex of Immunglobulin NEW at 3.5-A Resolution" Proc. Natl. Acad. Sci. USA 71(4):1427-1430 (Apr. 1974).
Baselga et al., "Phase II Study of Weekly Intravenous Recombinant Humanized Anti-p185/HER2 Monoclonal Antibody in Patients with HER2
eu-Overexpressing Metastatic Breast Cancer" J. Clin. Oncol. 14(3):737-744 (1996).
Beverley & Callard, "Distinctive functional charcteristics of human "T" lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody" European Journal of Immunology 11:329-334 (1981).
Bird et al., "Single-chain antigen-binding proteins" Science 242:423-426 (Oct. 1988).
Brennan et al., "Preparation of bispecific antibodies by chemical recombination of monoclonal immunoglobulin G.sub.1 fragments" Science 229:81-83 (Jul. 1985).
Bruccoleri et al., "Structure of antibody hypervariable loops reproduced by a conformational search algorithm" Nature 335:564-568 (Oct. 1988).
Caron et al., "Biological and Immunological Features of Humanized M195 (Anti-CD33) Monoclonal Antibodies" Cancer Research 52:6761-6767 (Dec. 1992).
Chothia & Lesk, "The relation between the divergence of sequence and structure in proteins" EMBO Journal 5(4):823-826 (1986).
Co & Queen, "Humanized antibodies for therapy" Nature 351:501-502 (Jun. 1991).
Co et al., "Chimeric and Humanized Antibodies with Specificity for the CD33 Antigen" J. of Immunology 148(4):1149-1154 (Feb. 1992).
Co et al., "Humanized Anti-Lewis Y Antibodies: In Vitro Properties and Pharmacokinetics in Rhesus Monkeys" Cancer Research 56:1118-1125 (Mar. 1996).
Colman et al., "Crystal and Molecular Structure of the Dimer of Variable Domains of the Bence-Jones Protein ROY" J. Mol. Biol. 116:73-79 (1977).
Colman et al., "Three-dimensional structure of a complex of antibody with influenza virus neuraminidase" Nature 326:358-363 (Mar. 1987).
Cook et al., "A map of the human immunoglbulin V.sub.H locus completed by analysis of the telometric region of chromosome 14q" Nature Genetics 7:162-168 (Jun. 1994).
Darsley & Rees, "Nucleotide sequences of
Carter Paul J.
Presta Leonard G.
Genentech Inc.
Hutzell Paula K.
Lee Wendy M.
Reeyes Julie E
LandOfFree
Humanized antibodies and methods for making them does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Humanized antibodies and methods for making them, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Humanized antibodies and methods for making them will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-992453